Nikhil Sudhir Sathe | Biological Networks | Best Researcher Award

Published on by Network Science

Dr. Nikhil Sudhir Sathe | Biological Networks | Best Researcher Award

Reliance Life Sciences Pvt Ltd | India

Dr. Nikhil Sudhir Sathe (PhD), currently associated with Laboratory Animal Research Services (LARS), is a distinguished researcher with over 20 years of expertise in drug discovery and preclinical evaluation of new chemical entities. His extensive professional experience encompasses in vitro genotoxicology, cell and microbial culture (aerobic, anaerobic, and viral systems including rabies virus), and small laboratory animal studies. Throughout his career at Reliance Life Sciences, Vimta Labs, Dabur Research Centre, and Wockhardt Research Centre, Dr. Sathe has demonstrated exceptional proficiency in GLP-compliant laboratory practices, including bacterial reverse mutation, chromosomal aberration, micronucleus, ELISA, cytotoxicity, and microbial monitoring assays. His early research contributions involved innovative in vitro models for evaluating the efficacy of antimicrobial and cosmetic products. Academically, he holds a Master’s and Bachelor’s degree in Microbiology from Shivaji University, Kolhapur, both with distinction. Dr. Sathe has contributed significantly to scientific literature with publications in reputed journals such as Vaccine, Microbial Pathogenesis, Infectious Medicine, and BioMed, focusing on bacteriophage therapy and vaccine development against multidrug-resistant pathogens and SARS-CoV-2. His scholarly achievements are complemented by active participation in national conferences and workshops, reflecting his deep commitment to advancing microbiological and biomedical research.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

"Unveiling Lytic Bacteriophages as Promising Biotherapeutics for the Control of Multidrug-Resistant Pseudomonas aeruginosa", CS Nikhil Sathe, Eugene Athan, Arnab Kapat, BioMed, 2025.

"Safety, immunogenicity and efficacy of Relcovax®, a dual receptor binding domain (RBD) and nucleocapsid (N) subunit protein vaccine candidate against SARS-CoV-2 virus", N Sathe, S Shaikh, M Bhavsar, L Parte, A Gadiparthi, S Kad, S Sensarma, Vaccine, 2024.

"Bacteriophage vB_kpnS-Kpn15: Unveiling its potential triumph against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae-Unraveling efficacy through innovative", N Sathe, C Suphioglu, E Athan, A Kapat, Microbial Pathogenesis, 2024.

"Pseudomonas aeruginosa: Infections and novel approaches to treatment “Knowing the enemy” the threat of Pseudomonas aeruginosa and exploring novel approaches to treatment", N Sathe, P Beech, L Croft, C Suphioglu, A Kapat, E Athan, Infectious medicine 2, 2023.

"Development of a novel therapy using bacteriophages: An alternative to antibiotics", NS Sathe, Deakin University, 2023.

Tamar Kinaciyan | Medicine | Best Research Article Award

Published on by Network Science

Dr. Tamar Kinaciyan | Medicine | Best Research Article Award

Department of Dermatotolgy, Medical University of Vienna | Austria

Author Profile

Scopus

Orcid ID

Early Academic Pursuits

Dr. Tamar Kinaciyan embarked on her medical and dermatological journey at the Medical University of Vienna, where she completed her dermatology board examination in 1996 and specialized in environmental medicine and clinical allergology. Her early academic roles included heading the Borrelia-Outpatient Clinic (1994–2000) and directing immune fluorescence microscopy and antigen-mapping laboratories for bullous and connective tissue diseases (1993–1998). She further strengthened her clinical research foundation through diplomas in dermatoscopy, clinical investigation, and lung function analysis, laying a solid groundwork for her career in pediatric dermatology and allergology.

Professional Endeavors

Dr. Kinaciyan’s professional trajectory spans nearly three decades, marked by leadership roles in both clinical and organizational settings. She serves as Head of the Allergy and Pediatric Dermatology Clinics at the Department of Dermatology, Medical University of Vienna, and leads multiple specialized centers, including ACARE, HAE, and UCARE. Her contributions extend to international collaboration through Ga2LEN ACARE Centers and to advocacy for women in science as founder and honorary president of the Women’s Science Network Medicine. She has also held numerous key roles in Austrian and European scientific societies, reflecting her commitment to both clinical excellence and professional mentorship.

Contributions and Research Focus

Dr. Kinaciyan’s research primarily focuses on hereditary angioedema, urticaria, mastocytosis, and pediatric dermatology, alongside investigations into food allergies, latex allergy, drug hypersensitivity, and eczema. She has led and participated in multiple clinical trials, EU projects, and Austrian national studies, including the Austrian Registry of Bradykinin-mediated Angioedema and studies on sublingual immunotherapy for birch pollen-related food allergies. Her work bridges clinical and translational research, advancing diagnostic and therapeutic approaches for rare and complex allergic and dermatologic conditions.

Impact and Influence

Her clinical and research expertise has significantly influenced European and global dermatology and allergology communities. Dr. Kinaciyan has chaired numerous congress sessions, contributed to guideline task forces, and served as an editorial board member for several high-impact journals, including the Journal of Exploration of Asthma & Allergy. Her mentorship and advocacy efforts, particularly through WNW-med, have empowered foreign-trained physicians and supported gender equity in medical sciences, establishing her as both a thought leader and a mentor.

Academic Citations

Dr. Kinaciyan has a strong publication record with 88 peer-reviewed, Medline-indexed articles, totaling an impact factor of 782.704 and an h-index of 28. Her contributions span original research, invited articles, book chapters, and case studies in prestigious journals and texts, reflecting her broad influence across allergology and dermatology.

Legacy and Future Contributions

Dr. Kinaciyan’s legacy lies in her dual commitment to advancing clinical dermatology and fostering the next generation of medical researchers. By integrating cutting-edge research with patient-centered care and promoting inclusive academic networks, she has set a standard for excellence in both practice and mentorship. Moving forward, her continued focus on hereditary angioedema, pediatric dermatology, and clinical allergology promises to deepen scientific understanding and improve patient outcomes globally.

Conclusion

Dr. Tamar Kinaciyan exemplifies a rare combination of clinical acumen, research innovation, and leadership. Her pioneering work in hereditary angioedema and pediatric dermatology, coupled with her dedication to professional development and mentorship, has left an indelible mark on the field. With a prolific publication record, numerous awards, and sustained international impact, she stands as a leading figure whose ongoing contributions continue to advance both science and patient care.

Notable Publications

“Diagnostic difficulties in pediatric annular dermatoses" 

  • Author: Doris Weiss; Philipp Weber; Amélie Hampel; Julia Tittes; Wolfgang Weninger; Tamar Kinaciyan
  • Journal: Wiener Medizinische Wochenschrift
  • Year: 2024

“The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation" 

  • Author: Buttgereit T; Aulenbacher F; Gutsche A; Kolkhir P; Weller K; Vera Ayala C; Magerl M; Farkas H; Grumach AS; Aygören-Pürsün E et al.
  • Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
  • Year: 2024

“Docetaxel‐induced symmetrical drug‐related intertriginous and flexural exanthema (SDRIFE) confirmed by skin testing" 

  • Author: Amélie Hampel; Tamar Kinaciyan
  • Journal: Contact Dermatitis
  • Year: 2024

“Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus" 

  • Author: Reshef A; Buttgereit T; Betschel SD; Caballero T; Farkas H; Grumach AS; Hide M; Jindal AK; Longhurst H; Peter J et al.
  • Journal: The Journal of allergy and clinical immunology
  • Year: 2024

“The changing epidemiology of human leishmaniasis in the non-endemic country of Austria between 2000 to 2021, including a congenital case." 

  • Author: Riebenbauer K; Czerny S; Egg M; Urban N; Kinaciyan T; Hampel A; Fidelsberger L; Karlhofer F; Porkert S; Walochnik J et al.
  • Journal: PLoS neglected tropical diseases
  • Year: 2024

 

 

 

June Round | Biological Networks | Best Researcher Award 

Published on by Network Science

Dr. June Round | Biological Networks | Best Researcher Award 

University of Utah | United States

Author Profiles

Scopus

Google Scholar

Early Academic Pursuits

Dr. June Round’s academic journey reflects a foundation of dedication and scholarly excellence. Beginning with a B.S. in Biology (Cum Laude) at California Lutheran University, she distinguished herself early through departmental honors and multiple scholarships. Her passion for molecular biology led to an M.S. from the University of the Pacific, followed by a D.Phil. in Microbiology, Immunology, and Molecular Genetics at UCLA, supported by highly competitive fellowships. Her formative postdoctoral training at the California Institute of Technology under Sarkis K. Mazmanian provided a strong platform to explore the intricate interplay between microbiota and host immunity, setting the stage for her pioneering career.

Professional Endeavors

Currently serving as a Professor at the University of Utah, Dr. Round has held numerous leadership roles including Director of the Mountain West Microbiota Alliance (MoWMA) and Co-Director of the Microbiota and GI Immunology Consortia (MAGIC). She has chaired multiple search committees, overseen postdoctoral studies, and contributed extensively to university-level, college-level, and departmental governance. Her sustained involvement in NIH study sections, national symposia, and scientific advisory boards underscores her standing as a leader in immunology and microbial pathogenesis.

Contributions and Research Focus

Dr. Round’s research focuses on microbiota–immune system interactions, particularly their role in regulating immune tolerance and driving inflammatory diseases. Her laboratory has produced high-impact work elucidating mechanisms by which commensal microbes shape host immunity, contributing to transformative understanding in immunology, microbiology, and gastrointestinal health. Her investigations into toll-like receptors, dysbiosis, and immune regulation have provided new frameworks for therapeutic exploration in autoimmune and inflammatory disorders.

Impact and Influence

The significance of Dr. Round’s research is reflected in her numerous prestigious awards, including the NIH Innovator Award, Packard Fellowship, Pew Scholar Award, Burroughs Wellcome Investigator in Pathogenesis, and the W.M. Keck Research Award. These honors not only recognize her innovative contributions but also demonstrate her influence in shaping the field. She has trained and mentored a generation of young scientists, many of whom now serve as professors, researchers, and clinicians in leading institutions worldwide—an enduring testament to her academic leadership.

Academic Citations and Recognition

Dr. Round’s scholarship has been widely published in top-tier journals including Cell, Nature Reviews Immunology, Science Immunology, and Annual Review of Microbiology. Her reviews and original research articles are highly cited, frequently shaping discourse in immunology and microbiome research. Her contributions extend beyond publications through book chapters and invited conference proceedings, amplifying her thought leadership in the global scientific community.

Legacy and Future Contributions

Dr. Round’s legacy lies in bridging microbiology and immunology, redefining the microbiota’s role in human health and disease. Through her pioneering studies, administrative leadership, and mentorship, she has cultivated a scientific ecosystem that will continue to grow. Moving forward, her leadership in major microbiome initiatives and consortia is poised to advance translational breakthroughs, from novel therapeutics for autoimmune disease to deeper insights into the human–microbe interface.

Conclusion

Dr. June Round’s career reflects the hallmarks of an exceptional researcher: rigorous scholarship, innovative vision, academic leadership, and transformative mentorship. Her pioneering contributions to microbiome and immune system research have reshaped fundamental scientific understanding while fostering future leaders in biomedical science. With her remarkable impact, both in the laboratory and across academic institutions, Dr. Round stands as an exemplary candidate for the Best Researcher Award.

Notable Publications

"Neonatal fungi promote lifelong metabolic health through macrophage-dependent β cell development" 

  • Author: JH Hill, R Bell, L Barrios, H Baird, K Ost, M Greenewood, JK Monts
  • Journal: Science
  • Year: 2025

"The gut microbiome is associated with disease‐free survival in stage I–III colorectal cancer patients" 

  • Author: DA Byrd, V Damerell, MF Gomez Morales, SR Hogue, T Lin, J Ose
  • Journal: International Journal of Cancer
  • Year: 2025

"A microRNA-regulated transcriptional state defines intratumoral CD8+ T cells that respond to immunotherapy" 

  • Author: WW Tang, B Battistone, KM Bauer, AM Weis, C Barba, MZH Fadlullah
  • Journal: Cell reports
  • Year: 2025

"Primary tumor microbiomes predict distant metastasis of colorectal cancer" 

  • Author: B Parajuli, V Midya, R Kiddle, N De Jager, S Eggers, D Spakowicz
  • Journal: Cell reports
  • Year: 2025

"Clec12a controls colitis by tempering inflammation and restricting expansion of specific commensals" 

  • Author: TR Chiaro, M Greenewood, KM Bauer, KS Ost, E Stephen-Victor
  • Journal: bioRxiv
  • Year: 2025